Research at Whitehead
Whitehead Institute provides researchers with the resources and freedom to follow their scientific instincts, form novel collaborations, and conduct high-risk research. While probing basic biological processes, the Institute’s 16 faculty Members and 2 Fellows develop innovative technologies and lay the foundation for projects that improve human health. They run pioneering programs in cancer, immunology, developmental biology, stem cell science, regenerative medicine, genetics, and genomics.
May 11, 2015
Using a mouse model, the lab of Whitehead Institute Founding Member Harvey Lodish, has now determined that combining the cholesterol-lowering drug fenofibrate with glucocorticoids could allow for dramatically lower steroid doses in the treatment of Diamond Blackfan anemia and other erythropoietin-resistant anemias.
May 6, 2015
Scientists have applied a new method of analyzing cell states to identify a gene required for breast stem cells to differentiate. This gene, RUNX1, is deregulated or mutated in some leukemias and breast cancers. The novel approach, known as PEACS, could also be used to screen for drugs that activate or inhibit the expression regulators of stem cell differentiation.
April 20, 2015
Imaging immunity: Noninvasive imaging of immune system detects tumors, could monitor therapeutic response
A novel approach that allows real-time imaging of the immune system’s response to the presence of tumors—without the need for blood draws or invasive biopsies—offers a potential breakthrough both in diagnostics and in the ability to monitor efficacy of cancer therapies.
April 8, 2015
Biologists at Whitehead Institute and MIT have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors.
March 26, 2015
Nutrient-sensing mechanisms across evolution.
Cell. 2015 Mar 26;161(1):67-83.
March 24, 2015
Chromatin proteomic profiling reveals novel proteins associated with histone-marked genomic regions.
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):3841-6.
March, 23, 2015
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
Nat Biotechnol. 2015 Mar 23.